Search research articles
Contact Us
Filters
Showing results (141-150 of 315) with videos related to
Page
of 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
Caron A Jacobson, Jason R Westin, David B Miklos, et al.
Blood
|
October 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma
Jooeun Bae, Shuichi Kitayama, Zach Herbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion
Wandi Zhang, Jaewon Choi, Wanyong Zeng, et al.
Blood
|
November 11, 2011
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
Mathangi Srinivasan, Ryan Flynn, Andrew Price, et al.
Frontiers in Oncology
|
May 30, 2024
Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma
Tamara A Sussman, Mariano Severgnini, Anita Giobbie-Hurder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation
John Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Blood Advances
|
May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
Katie Maurer, Vincent T Ho, Eno Inyang, et al.
Oncoimmunology
|
November 22, 2012
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients
Ana Brusic, Ursula Hainz, Martha Wadleigh, et al.
Nature Immunology
|
September 15, 2021
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias
Mahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
Blood
|
April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Vincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Page
of 32
Search research articles
Search
Showing results (141-150 of 315) with videos related to
Sort By:
Page
of 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
Caron A Jacobson, Jason R Westin, David B Miklos, et al.
Blood
|
October 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma
Jooeun Bae, Shuichi Kitayama, Zach Herbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion
Wandi Zhang, Jaewon Choi, Wanyong Zeng, et al.
Blood
|
November 11, 2011
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
Mathangi Srinivasan, Ryan Flynn, Andrew Price, et al.
Frontiers in Oncology
|
May 30, 2024
Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma
Tamara A Sussman, Mariano Severgnini, Anita Giobbie-Hurder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation
John Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Blood Advances
|
May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
Katie Maurer, Vincent T Ho, Eno Inyang, et al.
Oncoimmunology
|
November 22, 2012
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients
Ana Brusic, Ursula Hainz, Martha Wadleigh, et al.
Nature Immunology
|
September 15, 2021
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias
Mahesh Raundhal, Shrestha Ghosh, Samuel A Myers, et al.
Blood
|
April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Vincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Page
of 32